Rezipres Now Available for Intraoperative Hypotension
Rezipres is a ready-to-use formulation of injectable ephedrine hydrochloride.
Diagnosis & Disease Information
Vasostrict Now Available in Ready-to-Use Formulation
The new formulation is expected to save preparation time.
MPR Weekly Dose Podcast Episode 100
This week Pfizer seeks Emergency Use Authorization for their COVID-19 oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote endoscopy procedures; And the largest to date psilocybin trial shows promise in treatment-resistant depression.
Drugs Prescribed Widely for Common Conditions Linked to Orthostatic Hypotension
The meta-analysis included 69 RCTs with a total of 27,079 patients.
Ready-to-Use Norepinephrine Formulation Now Available
Norepinephrine is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states.
Study Evaluating Ampreloxetine for Neurogenic Orthostatic Hypotension Misses Endpoint
The phase 3 study was evaluating the efficacy and safety of ampreloxetine for the treatment of symptomatic neurogenic orthostatic hypotension in patients 30 years of age and older.
Rezipres Approved for Intraoperative Hypotension
The FDA has approved Rezipres (ephedrine hydrochloride) for the treatment of clinically important hypotension occurring in the setting of anesthesia.
Gender-Affirming Hormone Therapy Tied to Systolic BP Changes
Within two to four months, increases, decreases in systolic BP seen in transmasculine, transfeminine adults, respectively
Possible Sterility Breach Prompts Recall of Phenylephrine Hydrochloride Injection
A non-integral crimped vial overseal may result in a non-sterile product.
Emerphed Now Available for Intraoperative Hypotension
Nexus Pharmaceuticals announced the launch of Emerphed™, a premixed, ready-to-use formulation of ephedrine.
